- MEIJSTER. T., et al. "Exposure to Antineoplastic Drugs Outside the Hospital Environment", Ann Occup Hyg, 2006;50(7):657-64.
- BRYANT. C., B. CRANDELL. "Community Pharmacists’ Knowledge of and Attitudes Toward Oral Chemotherapy", JAPhA, 2008;48(5):632-9.
- SCHIERL, R., A. BÖHLANDT, D. NOWAK. "Guidance Values for Surface Monitoring of Antineoplastic Drugs in German Pharmacies", Ann Occup Hyg, 2009;53(7):703-11.
- BUSSIÈRES, J.-F., C. TANGUAY, A. SOULARD, M. LEFEBVRE, E. LANGLOIS. « Étude pilote sur la surveillance environnementale en pharmacie communautaire », Bulletin d’information toxicologique, 2010;26(3):15-19.
- HONGPING, D., Z. MEIBIAN, H. JILIANG, et al. "Investigating Genetic Damage in Workers Occupationally Exposed to Methotrexate Using Three Genetic End-Points", Mutagenesis, 2005; 20(5):351-357.
- SHAHIN, D., E.E. TORABY, H. ABDEL-MALEK, et al. "Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonist (Pioglitazone) and Methotrexate on Disease Activity in Rheumatoid Arthritis (Experimental and Clinical Study) ", Clin Med Insights Arthritis Musculoskelet Disord, 2011, Feb 7; 4:1-10.
- KESHAVA, C., N. KESHAVA, W.Z. WHONG, et al. "Inhibition of Methotrexate-Induced Chromosomal Damage by Vanillin and Chlorophyllin in V79 Cells", Teratog Carcinog Mutagen, 1997-1998; 17(6):313-26.
- SHAHSAVARANI, S., R.J. GODEFROID, B.R. HARRISON. Evaluation of Occupational Exposure to Tablet Trituration Dust, ASHP Midyear Clinical Meeting, 1993, P-59(E) abs.
- NATIONAL COMPREHENSIVE CANCER NETWORK. Oral Chemotherapy: Potential and Misconceptions, 2012.
- ASSTSAS. Manipulation sécuritaire des médicaments dangereux, Guide de prévention [en ligne] (lien consulté en novembre 2012).
- ORDRE DES PHARMACIENS DU QUÉBEC. « La manipulation des médicaments dangereux en pharmacie »,Bulletin d’informations professionnelles, mai 2010, no 169.
- MERGER, D., C. TANGUAY, J.-F. BUSSIÈRES. « Retombées des mises à jour de la liste des médicaments dangereux du NIOSH », Bulletin d’information toxicologique, 2012;28(3):32-54.
|